NYMOX PHARMACEUTICAL CORPORATION Adjustments For Decrease Increase In Trade Account Receivable
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Adjustments For Decrease Increase In Trade Account Receivable of -$12.00 thousand for the 9-month period ending 2024-09-30, per its 6-K filed 2025-01-02.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2025-01-02
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in trade account receivable for the quarter ending 2023-09-30 was $3.00K.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in trade account receivable for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in trade account receivable for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in trade account receivable for the quarter ending 2022-09-30 was -$1.00K, a 133.33% decline year-over-year.
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 3 month | Adjustments For Decrease Increase In Trade Account Receivable 6 month | Adjustments For Decrease Increase In Trade Account Receivable 9 month |
|---|---|---|---|
| 2024-09-30 | -$12.00K 6-K · filed 2025-01-02 | ||
| 2023-09-30 | $3.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-01-02 | $3.00K derived: sum of 2 quarters · filed 2025-01-02 | $3.00K 6-K · filed 2025-01-02 |
| 2023-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | $0.00 6-K · filed 2023-08-14 | |
| 2023-03-31 | $0.00 6-K · filed 2023-05-12 | ||
| 2022-09-30 | -$1.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-15 | $0.00 derived: sum of 2 quarters · filed 2023-11-15 | $3.00K 6-K · filed 2023-11-15 |
| 2022-06-30 | $1.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | $4.00K 6-K · filed 2023-08-14 | |
| 2022-03-31 | $3.00K 6-K · filed 2023-05-12 | ||
| 2021-09-30 | $3.00K derived: 6-K/A 9 month − 6-K 6 month · filed 2022-11-16 | $8.00K 6-K/A · filed 2022-11-16 | |
| 2021-06-30 | $5.00K 6-K · filed 2022-08-15 |